BioCardia
BCDA
10 hedge funds and large institutions have $228K invested in BioCardia in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 13 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
4.26% more ownership
Funds ownership: 0.5% → 4.76% (+4.3%)
55% less funds holding
Funds holding: 22 → 10 (-12)
71% less capital invested
Capital invested by funds: $791K → $228K (-$563K)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$223K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$48.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$90 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
-$285K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$153K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$45.2K |
| 4 |
FM
Family Management
New York
|
-$31.5K |
| 5 |
BlackRock
New York
|
-$18.7K |
BCDA Hedge Fund Activity: Q2 2024 in Review
10 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q2 2024, worth a combined $228K — down 71% from $791K a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of BCDA and 1 opened new positions — a net loss of 12 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $223K. The largest seller was CM Management, exiting entirely with an estimated $285K sold.
- 10 institutional investors held BioCardia (BCDA) as of Q2 2024, down from 22 in Q1 2024.
- Funds reported $228K of BioCardia stock for Q2 2024, down 71% quarter-over-quarter.
- 1 fund opened new BioCardia positions in Q2 2024 and 13 closed out, a net change of -12 holders.
- The largest BioCardia buyer in Q2 2024 was Susquehanna International Group, an estimated $223K added.
- The largest BioCardia seller in Q2 2024 was CM Management, an estimated $285K sold.
Based on aggregated 13F filings for Q2 2024.